title: Rituximab.
authors.affiliation: IDEC Pharmaceuticals, San Diego, CA 92121, USA. Pmultani@idecpharm.com
authors.forename: Pratik
authors.initials: P
authors.lastname: Multani
authors.forename: Christine A
authors.initials: CA
authors.lastname: White
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008223:Lymphoma / Q000145:classification / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab; D012449:Safety
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab